Humoral Serologic Response to the BNT162b2 Vaccine Afterallogeneic Haematopoietic Cell Transplantation

Objectives: Compared with the general population, patients after allogeneic hematopoietic cell transplantation (HCT) are at higher risk to develop severe disease or die from COVID-19. Immunosuppressive therapy and graft-vs-host disease (GVHD) may abrogate the ability of transplanted patients to moun...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeshurun, Moshe, Pasvolsky, Oren, Shargian, Liat, Yahav, Dafna, Rubinstein, Maly, Navon Sela, Michal, Wolach, Ofir, Ben-Zvi, Haim, Raanani, Pia, Rozovski, Uri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
722.Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701586/
http://dx.doi.org/10.1182/blood-2021-149979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701586/
http://dx.doi.org/10.1182/blood-2021-149979

Ejemplares similares